• 1.

    Ezzedine K, Pistone T, Guir V, Malvy D , 2010. Painful Buruli ulcer in a Malian visitor to France. Acta Dermatol Venereol 90: 424.

  • 2.

    Bessis D, Kempf M, Marsollier L , 2015. Mycobacterium ulcerans disease (Buruli ulcer) in Mali: a new potential African endemic country. Acta Dermatol Venereol 95: 489490.

    • Search Google Scholar
    • Export Citation
  • 3.

    Dupechez L, Carvalho P, Hebert V, Marsollier L, Eveillard M, Marion E, Kempf M , 2019. Senegal, a new potential endemic country for Buruli ulcer? Int J Infect Dis 89: 128130.

    • Search Google Scholar
    • Export Citation
  • 4.

    Turner GA et al.2019. Confirmed case of Buruli ulcer, Senegal, 2018. Emerg Infect Dis 25: 600601.

  • 5.

    Millogo A, Loukil A, Fellag M, Diallo B, Ouedraogo AS, Godreuil S, Drancourt M, 2020. Fluorescent hybridization of Mycobacterium leprae in skin samples collected in Burkina Faso. J Clin Microbiol 58: e02130-19.

  • 6.

    Fyfe JAM et al.2007. Development and application of two multiplex real-time PCR assays for the detection of Mycobacterium ulcerans in clinical and environmental samples. Appl Environ Microbiol 73: 47334740.

    • Search Google Scholar
    • Export Citation
  • 7.

    Food and Agriculture Organization , 2015. AQUASTAT Profil de Pays: Burkina Faso. Rome, Italy: Food and Agriculture Organization, 2.

  • 8.

    Ouoba K et al.1998. Les ulcères de Buruli au Burkina Faso: à propos de 6 observations. Tunis Med 76: 4650.

  • 9.

    Zeba SB et al.2018. Résultats de l’évaluation intégrée de la situation de la lèpre, de l’ulcère de Buruli et du pian autour des périmètres irrigués de Bagré et Kompienga au Burkina Faso. Ann Dermatol Venereol 145: S246.

    • Search Google Scholar
    • Export Citation
  • 10.

    Sears AV, Hay RJ , 2015. Commentary: Buruli ulcer: a rapidly changing scene. Acta Dermatol Venereol 95: 387388.

  • 11.

    Hammoudi N et al.2019. Investigation of skin microbiota reveals Mycobacterium ulceransAspergillus sp. trans-kingdom communication. BioRxiv Available at: https://doi.org/10.1101/869636.

    • Search Google Scholar
    • Export Citation
  • 12.

    Ackumey MM, Gyapong M, Pappoe M, Kwakye-Maclean C, Weiss MG , 2012. Illness meanings and experiences for pre-ulcer and ulcer conditions of Buruli ulcer in the Ga-West and Ga-South municipalities of Ghana. BMC Public Health 12: 264.

    • Search Google Scholar
    • Export Citation
  • 13.

    Abel AA, Lucien AD, Konan DO , 2016. Itineraires therapeutiques pluriels et recours tardif des malades de l’ulcère de Buruli dans les centres de Prise en Charge dans le district Sanitaire de Yamoussoukro (Côte d’Ivoire). ESJ 12: 264279.

    • Search Google Scholar
    • Export Citation
 
 
 

 

 
 
 

 

 

 

 

 

 

Confirming Autochthonous Buruli Ulcer Cases in Burkina Faso, West Africa

View More View Less
  • 1 Institut Hospitalo-Universitaire Méditerranée Infection, Marseille, France;
  • | 2 Université de Montpellier, Institut de Recherche pour le Développement, Maladies Infectieuses et Vecteurs: Ecologie, Génétique, Evolution et Contrôle, Montpellier, France;
  • | 3 Aix-Marseille-Univ., Institut de Recherche pour le Développement, Microbes, Evolution, Phylogénie et Infection, Institut Hospitalo-Universitaire Méditerranée Infection, Marseille, France;
  • | 4 Département des Laboratoires, Centre Hospitalier Universitaire Souro Sanou, Bobo-Dioulasso, Burkina Faso;
  • | 5 Centre Muraz, Bobo-Dioulasso, Burkina Faso

ABSTRACT.

Environmental Mycobacterium ulcerans causes a disabling skin disease called Buruli ulcer. Recent studies completed the knowledge of the evolving geographic extension and epidemiology of Buruli ulcer in West Africa, where Côte d’Ivoire is reporting the highest number of cases. We report seven polymerase chain reaction-documented patients in Burkina Faso, a neighboring country of Côte d’Ivoire, where previously Buruli ulcer cases were confirmed primarily using clinical arguments.

    • Supplemental Materials (DOCX 230 KB)

Author Notes

Address correspondence to Michel Drancourt, Aix-Marseille-Univ., IRD, MEPHI, IHU Méditerranée Infection, Marseille, France. E-mail: michel.drancourt@univ-amu.fr

Financial support: This work was supported by the French government under the Investissements d’Avenir (Investments for the Future) Program managed by the Agence Nationale de la Recherche (Méditerranée Infection 10-IAHU-03) and by Région Le Sud (Provence Alpes Côte d’Azur) and European funding (FEDER BIOTK).

Authors’ addresses: Anselme Millogo, IHU Méditerranée Infection, Marseille, France, Université de Montpellier, IRD, MIVEGEC, Montpellier, France, Aix-Marseille-Univ., IRD, MEPHI, IHU Méditerranée Infection, Marseille, France, and Département des Laboratoires, Centre Hospitalier Universitaire Souro Sanou, Bobo-Dioulasso, Burkina Faso, E-mail: fortius2000@yahoo.fr. Dezemon Zingue, Centre Muraz, Bobo-Dioulasso, Burkina Faso, E-mail: zinguedezemon@yahoo.fr. Amar Bouam, Michel Drancourt, and Nassim Hammoudi, IHU Méditerranée Infection, Marseille, France, and Aix-Marseille-Univ., IRD, MEPHI, IHU Méditerranée Infection, Marseille, France, E-mails: amarbouam@yahoo.fr, michel.drancourt@univ-amu.fr, and nassimveto15@live.fr. Sylvain Godreuil, Université de Montpellier, IRD, MIVEGEC, Montpellier, France, E-mail: s-godreuil@chu-montpellier.fr.

Save